English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 製薬企業関連 > 医薬品開発業務受託機関(CRO)の米国市場:主な治療分野
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

医薬品開発業務受託機関(CRO)の米国市場:主な治療分野

U.S. CRO Markets - Key Therapeutic Areas

発行 Frost & Sullivan
出版日 2009年07月 商品コード 94650
ページ情報 英文 71 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service provides a detailed overview and analysis of key therapeutic areas in the U.S. CRO Market. The research service includes a detailed analysis of market trends, industry challenges and key therapeutic areas. Revenue forecasts from 2010 to 2016 have also been included in this research service.

Table of Contents

1. EXECUTIVE SUMMARY

  • Executive Summary
    • 1. Introduction

2. MARKET INTRODUCTION

  • Research Scope and Methodology
    • 1. Scope and Segmentation
    • 2. Research Methodology
  • Market Overview
    • 1. Introduction
    • 2. Measurements
    • 3. Industry Challenges

3. MARKET ANALYSIS

  • Market Forecasts and Trends
    • 1. Market Forecasts
    • 2. Therapeutic Pipeline
  • Revenue Forecasts by Key Therapeutic Markets
    • 1. Oncology
    • 2. Infectious Diseases
    • 3. Central Nervous System
    • 4. Cardiovascular
    • 5. Metabolic Diseases
    • 6. Respiratory and Allergy
    • 7. Others

4. APPENDIX

  • Decision Support Databases
    • 1. Number of Biotech Companies
    • 2. Number of Physicians
    • 3. Private Healthcare Expenditure
    • 4. Total Healthcare Expenditure
    • 5. Total Population
Back to Top